Aclarion, Inc., a company listed on the Nasdaq Stock Market, has filed an amendment to its previous Form 8-K report with the Securities and Exchange Commission (SEC) due to a clerical error involving an incorrect exhibit attachment. The amendment, dated August 13, 2024, corrects the initial report filed on August 12, 2024. Additionally, Aclarion announced the entry into a material definitive agreement on August 12, 2024, where the company agreed to sell 400,000 shares of common stock to an institutional investor at $0.29 per share, resulting in gross proceeds of $116,000. The shares were offered at-the-market under Nasdaq rules following the company's Form 1-A Offering Statement, which was filed on June 11, 2024, and qualified on June 24, 2024. No placement agent was used, and no fees or commissions will...Show More

Aclarion, Inc., a company listed on the Nasdaq Stock Market, has filed an amendment to its previous Form 8-K report with the Securities and Exchange Commission (SEC) due to a clerical error involving an incorrect exhibit attachment. The amendment, dated August 13, 2024, corrects the initial report filed on August 12, 2024. Additionally, Aclarion announced the entry into a material definitive agreement on August 12, 2024, where the company agreed to sell 400,000 shares of common stock to an institutional investor at $0.29 per share, resulting in gross proceeds of $116,000. The shares were offered at-the-market under Nasdaq rules following the company's Form 1-A Offering Statement, which was filed on June 11, 2024, and qualified on June 24, 2024. No placement agent was used, and no fees or commissions will be paid for the transaction. Aclarion retains the option to raise additional funds up to approximately $29.68 million under the same terms, with future sales to be disclosed in subsequent prospectus supplements. However, there are currently no agreements in place for further sales, and the company cannot guarantee that any additional sales will occur.